Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer
Background: A marker of urothelial damage could be helpful for early detection and monitoring of local toxicity due to intravesical therapy for non-muscle invasive bladder cancer (NMIBC). The aim of the study was to investigate the correlation between fibronectin (FN) gene expression in bladder wash...
Main Authors: | Fabrizio Di Maida, Cristina Scalici Gesolfo, Riccardo Tellini, Andrea Mari, Chiara Sanfilippo, Luca Lambertini, Antonio Andrea Grosso, Marco Carini, Andrea Minervini, Vincenzo Serretta |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287221995683 |
Similar Items
-
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
by: Vincenzo Serretta, et al.
Published: (2015-01-01) -
Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01) -
Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review
by: Daher C. Chade, et al.
Published: (2009-12-01) -
The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer
by: Chi-Ping Huang, et al.
Published: (2018) -
Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer
by: Wojciech Krajewski, et al.
Published: (2014-03-01)